Bacterial Antigen
Bacterial Antigen - Related Videos
02:48
Fluorescence-Based Assay for Investigating Macrophage Receptor Interactions with Bacterial Antigens
0 Views •
2026
Source: Barbero, A. M., et.al. Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1. J. Vis. Exp. ( (2025)This video demonstrates a fluorescence-based assay to study the interaction between a macrophage receptor and Mycobacterium tuberculosis antigens. Fluorescently labeled antigens on a coverslip are incubated with macrophage protein extracts, cross-linked, antibody-labeled, and visualized by overlapping fluorescence signals.
03:52
Subcutaneous Injection of Bacterial Antigen to Induce Systemic Inflammation in a Murine Model
0 Views •
2025
This video demonstrates the induction of systemic inflammation in an anesthetized mouse. The injection of mycobacterial antigen-adjuvant depots triggers cytokine release and localized inflammation. Lymphatic vessels open, enabling immune cell entry into lymph nodes and activation of T cells, which release pro-inflammatory cytokines, leading to widespread inflammation.
02:44
Western Blot for Assessing the Structural Integrity of a Bacterial Vaccine Antigen
0 Views •
2025
Source: Gilmore, S. F. et al. Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development. J. Vis. Exp. (2022)This video demonstrates the use of Western blotting to evaluate the structural integrity of the major outer membrane protein (MOMP) within nanoparticle-based vaccine complexes. It outlines the key steps involved in protein transfer, antibody labeling, and fluorescence imaging.
06:57
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
0 Views •
Cited by 9 •
2016
In this antigen-driven colitis model, OT-II CD4+ T cells expressing a red fluorescent protein were adoptively transferred into RAG-/- mice that express a green fluorescent protein in mononuclear phagocytes (MPs). The hosts were challenged with Escherichia coli (E.coli) expressing the ovalbumin protein (OVA) fused to a cyan fluorescent protein (CFP).
05:04
Viral Antigen Microarray Assay to Detect Antibody Isotypes in Serum Against Viral Antigen
0 Views •
2025
In this video, we demonstrate the process for detecting antibody isotypes in multiple human serum samples using a microarray slide printed with antigenic subtypes of influenza virus strains.
FAQs
The immune response depends on which epitope, or recognizable molecular region, is available to immune cells. Antigen-presenting cells process suitable fragments for display on major histocompatibility complex molecules, supporting T-cell activation, while B cells recognize matching surface structures and produce antibodies. This division allows cellular and antibody-mediated responses to address different features of the same bacterium.
Surface proteins, polysaccharides, and toxins present different molecular features to the immune system. Their distinct structures determine which epitopes can be captured, processed, or bound by antibodies. Comparing these antigen types helps researchers examine why immune responses differ among bacterial components and supports the selection of informative targets for detection or vaccine research.
Antigen recognition describes how immune components identify a bacterial structure, whereas antigen detection uses that recognition as an experimental or diagnostic signal. Antibodies that bind a matching antigen can reveal the presence of bacterial material, while cellular processing and presentation provide information about potential immune activation. These approaches answer related but different research questions.
Bacterial antigens provide defined microbial signals for examining immune activity associated with the brain, spinal cord, and peripheral nerves. In studies of meningitis or other infection-related inflammation, researchers can assess how antigen-driven immune responses relate to neural tissues and function. This connects microbial exposure with mechanisms that may affect nervous-system biology without treating every bacterial component as equivalent.
Detection studies can exploit the specific binding between an antigen and a matching antibody. Researchers select bacterial structures that provide recognizable targets, then evaluate whether immune binding indicates the presence of bacterial material. This application complements broader immune studies because it focuses on identifying a pathogen-associated signal rather than characterizing the full cellular response to it.
Vaccine research uses bacterial antigens as candidate targets for generating protective immune recognition. Investigators can compare surface proteins, polysaccharides, or other bacterial components according to their ability to present recognizable epitopes and stimulate antibody-related or cellular responses. The resulting antigen choices help guide studies aimed at preparing the immune system to respond to bacterial infection.
Defined bacterial antigens allow investigators to examine microbial influences on neural systems in a more focused way than using an undifferentiated infection signal. Studies can relate antigen-associated immune activity to the brain, spinal cord, or peripheral nerves, while also considering inflammatory responses. This framework supports research on how immune recognition may interact with neural function.
These experiments can connect specific bacterial molecular targets with immune events relevant to nervous-system tissues. Depending on the research design, findings may clarify antigen presentation, antibody binding, neuroinflammation associated with meningitis, or responses in peripheral nerves. Such results help distinguish the presence of bacterial material from the downstream immune processes that may influence neural biology.